OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
4
Results
Show all
Save search
Copy query
Show results for
Unknown
(4)
Publication Date
Release Date
2017
(1)
2016
(1)
2015
(1)
2014
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma.
Not available
S-EPMC5569683
|
biostudies-literature
Cite
Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort.
Not available
S-EPMC4985049
|
biostudies-literature
Cite
StrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors.
Not available
S-EPMC5430095
|
biostudies-literature
Cite
Integrative analysis of 111 reference human epigenomes.
Not available
S-EPMC4530010
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets